Lunit builds FDA-cleared AI diagnostic tools for chest X-ray and mammography screening, deployed across 3,500+ clinical sites globally. The tech stack spans Python, Go, TypeScript, and Kubernetes with distributed GPU training infrastructure—a signal of heavy model-development and inference workload. Hiring velocity is accelerating, but the department mix reveals organizational tension: research (3), support (3), ops (2), and product (2) outpace engineering (1), suggesting product-market fit in clinical adoption has outrun internal platform capacity, and oncology biomarker development is pulling engineering resources away from core platform work.
Notable leadership hires: Medical Director
Lunit is a Seoul-based public company developing medical AI software for cancer screening and detection. The product suite includes INSIGHT CXR (chest X-ray), INSIGHT MMG (2D mammography), INSIGHT DBT (digital breast tomosynthesis), and CXR Triage (emergency department triage in the US). The company's AI models have been validated across 100+ peer-reviewed publications and are integrated into radiology workflows at 3,500+ sites across the US, South Korea, Japan, and other markets. Commercial operations span bid support, sales engineering, and hospital platform integration, while research and clinical teams are actively developing AI-powered oncology biomarkers for expansion beyond screening into treatment.
Python, Go, TypeScript, React, PostgreSQL, Kafka, Kubernetes, Docker, AWS, GCP, Azure. Salesforce for CRM, PACS and HL7 for medical imaging/interoperability, Argo CD for deployment, Prometheus/Grafana/Loki for observability, Apache Airflow and Prefect for data pipelines.
3,500+ clinical sites globally deploy Lunit's AI products (INSIGHT CXR, MMG, DBT). The software is validated through 100+ peer-reviewed publications in journals including JAMA Oncology, Lancet Digital Health, and Radiology.
Lunit has 16 active roles with accelerating hiring velocity. Engineering openings are limited (1 posted role), but research (3), support (3), ops (2), and product (2) are actively recruiting across the US, South Korea, and Japan.
Lunit Cancer Screening's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.